We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Modified Form of Curcumin is a Promising Alzheimer's Drug

News   Jan 10, 2018 | Original Story from the Salk Institute

 
Targeting Mitochondrial ATP Synthase to Treat Alzheimer's
 
 
 

RELATED ARTICLES

A Way to Enhance Adsorption of Chemotherapy Drugs

News

A new study demonstrates adsorption of chemotherapy drugs onto active carbon delivery capsule can be enhanced with aluminium atom inclusions.

READ MORE

Brain's Lymphatic Vessels as New Avenue to Treat Multiple Sclerosis

News

“Our data suggests that there is a signal coming from the brain to the lymph nodes that tells immune cells to get back into the brain, causing the MS pathology,”

READ MORE

Scientists Determine Four Personality Types Based on New Data

News

The findings potentially could be of interest to hiring managers and mental health care providers.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE